bradykinin, des-arg(9)- has been researched along with Pneumonia, Viral in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roche, JA; Roche, R | 1 |
| Danser, AHJ; de Maat, S; de Mast, Q; Maas, C; van de Veerdonk, FL | 1 |
1 review(s) available for bradykinin, des-arg(9)- and Pneumonia, Viral
| Article | Year |
|---|---|
Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Betacoronavirus; Bradykinin; Chick Embryo; Coronavirus Infections; COVID-19; Disease Models, Animal; Humans; Kininogens; Mice; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Pulmonary Edema; Renin-Angiotensin System; SARS-CoV-2 | 2020 |
1 other study(ies) available for bradykinin, des-arg(9)- and Pneumonia, Viral
| Article | Year |
|---|---|
A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications.
Topics: Angiotensin-Converting Enzyme 2; Betacoronavirus; Bradykinin; Bradykinin B2 Receptor Antagonists; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dyspnea; Feedback, Physiological; Humans; Inflammation; Models, Biological; Off-Label Use; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptors, Bradykinin; Receptors, Virus; SARS-CoV-2 | 2020 |